Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening

We present four FIPA kindred discussing clinical and molecular data and emphasizing the differences regarding AIP status, as well as the importance of genetic screening. Family 1 consists of five patients harboring somatotropinomas with germline E24X mutation in AIP. In one of the patients, acromegaly was diagnosed through active screening, being cured by surgery. Families 2 and 3 are composed of two patients with non-functioning pituitary adenomas. Family 4 comprises patients harboring a prolactinoma and a somatotropinoma. No mutations in AIP were found in these families. No patient in Family 1 was controlled with octreotide treatment, while the acromegalic patient in Family 4 was controlled with octreotide LAR. In conclusion, FIPA is a heterogeneous condition, which may be associated with AIP mutation. Genomic and clinical screening is recommended in families with two or more members harboring pituitary adenomas, allowing early diagnosis and better outcome.

Bibliographic Details

Main Authors:	Pinho,Leandro Kasuki Jomori de, Vieira Neto,Leonardo, Wildemberg,Luiz Eduardo Armondi, Moraes,Aline Barbosa, Takiya,Christina M., Frohman,Lawrence A., Korbonits,Márta, Gadelha,Mônica R.
Format:	Digital revista
Language:	English
Published:	Sociedade Brasileira de Endocrinologia e Metabologia 2010
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302010000800006
Tags:	Add Tag No Tags, Be the first to tag this record!